
7 companies in F-Prime Capital's investment portfolio.
Back to F-Prime Capital profile“Healthcare and technology investor focusing on companies that improve human health and transform industries through data and technology.”
Digital pharmacy that provides prescription delivery services with a focus on customer experience and medication management.
Discord is an instant messaging and VoIP social platform that allows communication through voice calls, video calls, text messaging, and media.
Healthcare technology company that develops software to accelerate cancer research and improve patient care through real-world evidence.
Drill Sergeant Mindstrong (Brain Cadets in the PAL region) known in Japan as Onitore - Kyoukan wa Onigunsou (オニトレ~教官は鬼軍曹~) is a military recruit training-themed party video game developed by Japanese studio HI Corporation and published by Xseed Games for WiiWare.
Quartet Health provides a collaborative care platform that connects primary care providers with mental health specialists for integrated patient care.
Roman Health Ventures Inc., doing business as Ro, is an American telehealth company that diagnoses patients, and subsequently prescribes and delivers treatments and ongoing care.
Genomic diagnostics company that develops molecular tests to help physicians make treatment decisions for patients with thyroid, lung, and breast diseases.
F-Prime Capital has built a portfolio of 7 companies across 3 sectors, including Biotech, DevTools, Digital Health.
The portfolio reflects investments across the IPO, Series B, Series C stages, showing F-Prime Capital's approach to supporting companies at multiple points in their growth journey.
F-Prime Capital has invested in 7+ companies across 3 different sectors.
F-Prime Capital's portfolio spans Biotech, DevTools, Digital Health. This diversification reflects the firm's broad investment thesis and sector expertise.
F-Prime Capital invests across the IPO, Series B, Series C stages. Their portfolio includes companies at various points in their growth journey.